Atlas Trials

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Clinical trial NCT00372489 · TERMINATED

Trial details

NCT number
NCT00372489
Sponsor
Affymax
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Renal FailureChronic Kidney DiseaseAnemia
Start date
2006-09-01
Primary completion
2009-11-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.